Mucins in pancreatic cancer and its microenvironment

Sukwinder Kaur, Sushil Kumar, Navneet Momi, Aaron R. Sasson, Surinder Kumar Batra

Research output: Contribution to journalReview article

113 Citations (Scopus)

Abstract

Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic resistance, frequent recurrence and the absence of treatment strategies that specifically target the tumour and its supporting stroma. Deregulated cell-surface proteins drive neoplastic transformations and are envisioned to mediate crosstalk between the tumour and its microenvironment. Emerging studies have elaborated on the role of mucins in diverse biological functions, including enhanced tumorigenicity, invasiveness, metastasis and drug resistance through their characteristic O-linked and N-linked oligosaccharides (glycans), extended structures and unique domains. Multiple mucin domains differentially interact and regulate different components of the tumour microenvironment. This Review discusses: the expression pattern of various mucins in the pancreas under healthy, inflammatory, and cancerous conditions; the context-dependent attributes of mucins that differ under healthy and pathological conditions; the contribution of the tumour microenvironment in pancreatic cancer development and/or progression; diagnostic and/or prognostic efficacy of mucins; and mucin-based therapeutic strategies. Overall, this information should help to delineate the intricacies of pancreatic cancer by exploring the family of mucins, which, through various mechanisms in both tumour cells and the microenvironment, worsen disease outcome.

Original languageEnglish (US)
Pages (from-to)607-620
Number of pages14
JournalNature Reviews Gastroenterology and Hepatology
Volume10
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Tumor Microenvironment
Mucins
Pancreatic Neoplasms
Cellular Microenvironment
Oligosaccharides
Drug Resistance
Polysaccharides
Pancreas
Neoplasms
Membrane Proteins
Neoplasm Metastasis
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Mucins in pancreatic cancer and its microenvironment. / Kaur, Sukwinder; Kumar, Sushil; Momi, Navneet; Sasson, Aaron R.; Batra, Surinder Kumar.

In: Nature Reviews Gastroenterology and Hepatology, Vol. 10, No. 10, 01.10.2013, p. 607-620.

Research output: Contribution to journalReview article

@article{3a6537c3cd1646b88e1700e078afeb10,
title = "Mucins in pancreatic cancer and its microenvironment",
abstract = "Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic resistance, frequent recurrence and the absence of treatment strategies that specifically target the tumour and its supporting stroma. Deregulated cell-surface proteins drive neoplastic transformations and are envisioned to mediate crosstalk between the tumour and its microenvironment. Emerging studies have elaborated on the role of mucins in diverse biological functions, including enhanced tumorigenicity, invasiveness, metastasis and drug resistance through their characteristic O-linked and N-linked oligosaccharides (glycans), extended structures and unique domains. Multiple mucin domains differentially interact and regulate different components of the tumour microenvironment. This Review discusses: the expression pattern of various mucins in the pancreas under healthy, inflammatory, and cancerous conditions; the context-dependent attributes of mucins that differ under healthy and pathological conditions; the contribution of the tumour microenvironment in pancreatic cancer development and/or progression; diagnostic and/or prognostic efficacy of mucins; and mucin-based therapeutic strategies. Overall, this information should help to delineate the intricacies of pancreatic cancer by exploring the family of mucins, which, through various mechanisms in both tumour cells and the microenvironment, worsen disease outcome.",
author = "Sukwinder Kaur and Sushil Kumar and Navneet Momi and Sasson, {Aaron R.} and Batra, {Surinder Kumar}",
year = "2013",
month = "10",
day = "1",
doi = "10.1038/nrgastro.2013.120",
language = "English (US)",
volume = "10",
pages = "607--620",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Mucins in pancreatic cancer and its microenvironment

AU - Kaur, Sukwinder

AU - Kumar, Sushil

AU - Momi, Navneet

AU - Sasson, Aaron R.

AU - Batra, Surinder Kumar

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic resistance, frequent recurrence and the absence of treatment strategies that specifically target the tumour and its supporting stroma. Deregulated cell-surface proteins drive neoplastic transformations and are envisioned to mediate crosstalk between the tumour and its microenvironment. Emerging studies have elaborated on the role of mucins in diverse biological functions, including enhanced tumorigenicity, invasiveness, metastasis and drug resistance through their characteristic O-linked and N-linked oligosaccharides (glycans), extended structures and unique domains. Multiple mucin domains differentially interact and regulate different components of the tumour microenvironment. This Review discusses: the expression pattern of various mucins in the pancreas under healthy, inflammatory, and cancerous conditions; the context-dependent attributes of mucins that differ under healthy and pathological conditions; the contribution of the tumour microenvironment in pancreatic cancer development and/or progression; diagnostic and/or prognostic efficacy of mucins; and mucin-based therapeutic strategies. Overall, this information should help to delineate the intricacies of pancreatic cancer by exploring the family of mucins, which, through various mechanisms in both tumour cells and the microenvironment, worsen disease outcome.

AB - Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic resistance, frequent recurrence and the absence of treatment strategies that specifically target the tumour and its supporting stroma. Deregulated cell-surface proteins drive neoplastic transformations and are envisioned to mediate crosstalk between the tumour and its microenvironment. Emerging studies have elaborated on the role of mucins in diverse biological functions, including enhanced tumorigenicity, invasiveness, metastasis and drug resistance through their characteristic O-linked and N-linked oligosaccharides (glycans), extended structures and unique domains. Multiple mucin domains differentially interact and regulate different components of the tumour microenvironment. This Review discusses: the expression pattern of various mucins in the pancreas under healthy, inflammatory, and cancerous conditions; the context-dependent attributes of mucins that differ under healthy and pathological conditions; the contribution of the tumour microenvironment in pancreatic cancer development and/or progression; diagnostic and/or prognostic efficacy of mucins; and mucin-based therapeutic strategies. Overall, this information should help to delineate the intricacies of pancreatic cancer by exploring the family of mucins, which, through various mechanisms in both tumour cells and the microenvironment, worsen disease outcome.

UR - http://www.scopus.com/inward/record.url?scp=84885289630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885289630&partnerID=8YFLogxK

U2 - 10.1038/nrgastro.2013.120

DO - 10.1038/nrgastro.2013.120

M3 - Review article

C2 - 23856888

AN - SCOPUS:84885289630

VL - 10

SP - 607

EP - 620

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 10

ER -